Learn More
—Three versions of a novel adaptive channel estimation approach, exploiting the over-sampled complex exponential basis expansion model (CE-BEM), is presented for doubly selective channels , where we track the BEM coefficients rather than the channel tap gains. Since the time-varying nature of the channel is well captured in the CE-BEM by the known(More)
BACKGROUND As of 2010, the rivastigmine patch was licensed for the treatment of Alzheimer's disease (AD) in 64 countries. METHODS This 24-week, multicenter, randomized, double-blind, placebo-controlled study evaluated the efficacy, safety and tolerability of the 5-cm(2) (9-mg loading dose; 4.6 mg/24 h delivery rate) and 10-cm(2) (18-mg loading dose; 9.5(More)
INTRODUCTION Dapagliflozin treatment when added to insulin therapy in Japanese patients with type 2 diabetes remains to be evaluated. MATERIALS AND METHODS This was a multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate efficacy (at 16 weeks) and long-term safety (at 52 weeks) of dapagliflozin in addition to insulin(More)
Axo-glial interactions are critical for myelination and the domain organization of myelinated fibers. Cell adhesion molecules belonging to the Cadm family, and in particular Cadm3 (axonal) and its heterophilic binding partner Cadm4 (Schwann cell), mediate these interactions along the internode. Using targeted shRNA-mediated knockdown, we show that the(More)
We present a decision-directed tracking approach to doubly-selective channel estimation exploiting the complex exponential basis expansion model (CE-BEM). The time-varying nature of the channel is well captured by the CE-BEM while the time-variations of the (unknown) BEM coefficients are likely much slower than those of the channel. We track the BEM(More)